Acuity Pharmaceuticals acuitypharma.com

OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed throughout the eye, including uptake into the retina. In two tissue distribution and pharmacokinetic studies in rabbits, results showed that bevasiranib was present in the retina and in targeted retinal pigment epithelium (RPE) cells following intravitreal injection.

OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed throughout the eye, including uptake into the ret...Show all

See All Exits Recent Exits

Phone: 305-575-4100

Fax:

4400 Biscayne Boulevard

Miami, 33137
Florida, United States

Acuity Pharmaceuticals - Investments & Acquisitions

Show Real Data Acuity Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-12-22FineTech PharmaceuticalAcquiredOPKO Health
See all 1 investments